Literature DB >> 17475795

Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal.

Hao Huang1, Claudio Acuna-Goycolea, Ying Li, H M Cheng, Karl Obrietan, Anthony N van den Pol.   

Abstract

Cannabinoids modulate energy homeostasis and decrease cognitive arousal, possibly by acting on hypothalamic neurons including those that synthesize melanin-concentrating hormone (MCH) or hypocretin/orexin. Using patch-clamp recordings, we compared the actions of cannabinoid agonists and antagonists on identified MCH or hypocretin neurons in green fluorescent protein-expressing transgenic mice. The cannabinoid type-1 receptor (CB1R) agonist R-(+)-[2,3-dihydro-5-methyl-3-(4-morpho linylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate (WIN55,212,2) depolarized MCH cells and increased spike frequency; in contrast, WIN55,212,2 hyperpolarized and reduced spontaneous firing of the neighboring hypocretin cells, both results consistent with reduced activity seen with intracerebral cannabinoid infusions. These effects were prevented by AM251 [N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide], a CB1R antagonist, and by tetrodotoxin, suggesting no postsynaptic effect on either neuron type. In MCH cells, depolarizing WIN55,212,2 actions were abolished by the GABA(A) receptor antagonist bicuculline, suggesting that the CB1R-mediated depolarization was attributable to reduced synaptic GABA release. WIN55,212,2 decreased spontaneous IPSCs, reduced the frequency but not amplitude of miniature IPSCs, and reduced electrically evoked synaptic currents in MCH cells. Glutamate microdrop experiments suggest that WIN55,212,2 acted on axons arising from lateral hypothalamus local inhibitory cells that innervate MCH neurons. In hypocretin neurons, the reduced spike frequency induced by WIN55,212,2 was attributable to presynaptic attenuation of glutamate release; CB1R agonists depressed spontaneous and evoked glutamatergic currents and reduced the frequency of miniature EPSCs. Cannabinoid actions on hypocretin neurons were abolished by ionotropic glutamate receptor antagonists. Together, these results show that cannabinoids have opposite effects on MCH and hypocretin neurons. These opposing actions could help explain the increase in feeding and reduction in arousal induced by cannabinoids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475795      PMCID: PMC6672093          DOI: 10.1523/JNEUROSCI.0732-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

Authors:  J Simiand; M Keane; P E Keane; P Soubrié
Journal:  Behav Pharmacol       Date:  1998-03       Impact factor: 2.293

2.  Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.

Authors:  I Katona; B Sperlágh; A Sík; A Käfalvi; E S Vizi; K Mackie; T F Freund
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

3.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons.

Authors:  P Schweitzer
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

5.  Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.

Authors:  C M Williams; T C Kirkham
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

6.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

9.  Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

Authors:  S Hao; Y Avraham; R Mechoulam; E M Berry
Journal:  Eur J Pharmacol       Date:  2000-03-31       Impact factor: 4.432

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  29 in total

1.  Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity.

Authors:  Laura H Jacobson; S Renee Commerford; Sarah P Gerber; Yu Alice Chen; Beatriz Dardik; Frederique Chaperon; Chad Schwartzkopf; Van Nguyen-Tran; Thomas Hollenbeck; Peter McNamara; Xiaohui He; Hong Liu; H Martin Seidel; Anne-Liese Jaton; Jesper Gromada; Sandra Teixeira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-25       Impact factor: 3.000

2.  Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits.

Authors:  Karen M Crosby; Wataru Inoue; Quentin J Pittman; Jaideep S Bains
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

3.  FAAH deficiency promotes energy storage and enhances the motivation for food.

Authors:  C Touriño; F Oveisi; J Lockney; D Piomelli; R Maldonado
Journal:  Int J Obes (Lond)       Date:  2009-12-22       Impact factor: 5.095

Review 4.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

5.  Short-term high-fat diet primes excitatory synapses for long-term depression in orexin neurons.

Authors:  Victoria Linehan; Lisa Z Fang; Michiru Hirasawa
Journal:  J Physiol       Date:  2017-12-18       Impact factor: 5.182

Review 6.  Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour.

Authors:  Patricia Bonnavion; Laura E Mickelsen; Akie Fujita; Luis de Lecea; Alexander C Jackson
Journal:  J Physiol       Date:  2016-07-19       Impact factor: 5.182

Review 7.  The hypocretin/orexin system: implications for drug reward and relapse.

Authors:  Ainhoa Plaza-Zabala; Rafael Maldonado; Fernando Berrendero
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 8.  Sex differences in the cannabinoid regulation of energy homeostasis.

Authors:  Borzoo Farhang; Shanna Diaz; Stephanie L Tang; Edward J Wagner
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

9.  Estrogen rapidly attenuates cannabinoid-induced changes in energy homeostasis.

Authors:  Brian A Kellert; Mike C Nguyen; Cara Nguyen; Que H Nguyen; Edward J Wagner
Journal:  Eur J Pharmacol       Date:  2009-09-14       Impact factor: 4.432

10.  Sex differences in the cannabinoid modulation of appetite, body temperature and neurotransmission at POMC synapses.

Authors:  Shanna Diaz; Borzoo Farhang; Joshua Hoien; Megan Stahlman; Nadira Adatia; Jeremy M Cox; Edward J Wagner
Journal:  Neuroendocrinology       Date:  2009-01-09       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.